Ancillary and procedural lines decide whether independence pencils out.
Independent cardiology carries echo, nuclear, vascular, device clinic, and often cath and office-based lab work. Those lines are capital intensive and exposed to payer policy and site-of-service rules, so margin can move sharply while visit volume looks steady. The monthly briefing reads each line on its own contribution alongside access, staffing, and collections.
Where the specialty stands
Cardiology relies heavily on services such as nuclear imaging, echo, catheterization, and electrophysiology. Some groups are reconsidering independence as payers and CMS revalue office-based and ASC-based cardiovascular procedures. Imaging accreditation, device clinic throughput, and cardiovascular ASC strategy all affect margin.
- CMS has been rebuilding office- and ASC-based cardiovascular procedure payment, reopening the case for independence and de-novo cardiovascular ASCs.
- In-office ancillaries (nuclear, echo, vascular, device/remote-monitoring clinics) remain the core margin engine.
- Remote patient monitoring and CIED remote interrogation are recurring-revenue lines with their own staffing and compliance needs.
- Value-based cardiology and bundled cardiac episodes are expanding among larger groups.
- Private equity and large cardiovascular platforms (US Heart & Vascular-style) are actively consolidating independent groups.
What the briefing reads for a cardiology practice
Echo, nuclear, stress, and vascular studies read on volume, reimbursement, and direct cost. Equipment and technologist cost make these lines sensitive to small volume changes.
Cath, peripheral, and electrophysiology work by site of service, including any facility participation. Where a case is performed changes practice income materially.
Enrolled patients, billed monitoring intervals, and the staffing required to keep them current. Revenue leaks here are usually workflow, not payer behavior.
Third next available, new patient share, and referral source patterns. Referral shifts toward hospital-employed groups show up in new patient volume first.
Registry and quality program requirements read as both revenue and administrative cost, since the work is real and rarely counted.
Illustrative reference ranges
Read the methodologyThese internally authored, industry-informed estimates provide specialty context. They are not live peer data, licensed survey medians, targets, or promises.
| Indicator | Lower reference | Central reference | Upper reference |
|---|---|---|---|
| Revenue per provider (monthly) | $95k | $125k | $158k |
| Days in A/R | 32 days | 40 days | 48 days |
| Average reimbursement rate | 64% | 72% | 80% |
| Operating expense ratio | 60% | 66% | 72% |
| Scheduling efficiency | 74% | 82% | 89% |
| Quality compliance rate | 88% | 93% | 96% |
| Net collection rate | 93.6% | 96.2% | 98% |
| Contractual adjustment rate | 25% | 31% | 37% |
| Commercial payer mix | 44% | 56% | 68% |
| Third next available appointment | 6 days | 11 days | 17 days |
| No-show rate | 4.5% | 7% | 9.5% |
| Staff per provider | 3.3 | 4 | 4.7 |
| Provider turnover | 4% | 7% | 11% |
| Training investment (% of payroll) | 1.3% | 2.1% | 2.9% |
| Cost per visit | $215 | $260 | $320 |
| Patient satisfaction | 4.2 / 5 | 4.5 / 5 | 4.7 / 5 |
Questions this briefing is built to answer
- Which diagnostic lines are profitable after equipment and technologist cost?
- What is site of service doing to income on our procedural work?
- Are all eligible remote monitoring intervals being captured and billed?
- Where are our referrals going, and is that pattern changing?
- Is new equipment likely to pay for itself at our current volume?
- What is quality program participation costing us in staff time?
What we read to stay current
See what this looks like for your practice
Send aggregate practice data for a recent period and we will show you the executive brief format: what changed, why it may matter, likely drivers, and what to watch.
AileronMD analyzes business, financial, and operational data only. Do not submit patient records or protected health information. AileronMD does not provide clinical or medical advice, and does not guarantee financial results. Guidance is advisory; practice leadership makes the decisions.